Chargement en cours...
ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
NK-92 cells, and their derivative, designated aNK, were obtained from a patient with non-Hodgkin lymphoma. Prior clinical studies employing adoptively transferred irradiated aNK cells have provided evidence of clinical benefit and an acceptable safety profile. aNK cells have now been engineered to e...
Enregistré dans:
| Publié dans: | Int J Cancer |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5604238/ https://ncbi.nlm.nih.gov/pubmed/28477372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30767 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|